Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-108459 single-dose IV in atrial fibrillation
jRCT2080221673Phase 1
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Atrial fibrillation (AFib) comparing OPC-108459 IV with Placebo IV (2 arms). Primary endpoints: Safety of single-dose intravenous OPC-108459, Pharmacokinetics of OPC-108459 and 1 more.
02
Drugs
OPC-108459
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080221673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221673.